SOCS3 expression is inversely correlated with Pyk2 in non-small cell lung cancer and exogenous SOCS3 inhibits proliferation and invasion of A549 cells

Pathology

Volumn 44, Issue 5, 2012, Pages 434-440

  Zhang, Siyang ^a   Wang, Wei ^a   Wang, Enhua ^a   Qiu, Xueshan ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Apoptosis; Invasion; NSCLC; Proliferation; Pyk2; SOCS3

Indexed keywords

FOCAL ADHESION KINASE 2; SOCS3 PROTEIN, HUMAN; SUPPRESSOR OF CYTOKINE SIGNALING;

ADENOCARCINOMA; APOPTOSIS; CELL MOTION; CELL PROLIFERATION; CONFERENCE PAPER; DNA METHYLATION; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENETICS; HUMAN; IMMUNOHISTOCHEMISTRY; LUNG ADENOCARCINOMA; LUNG NON SMALL CELL CANCER; LUNG TUMOR; METABOLISM; PATHOLOGY; PHYSIOLOGY; RETROSPECTIVE STUDY; SQUAMOUS CELL CARCINOMA; STATISTICS; TUMOR CELL LINE; UPREGULATION;

ADENOCARCINOMA; APOPTOSIS; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; DNA METHYLATION; FOCAL ADHESION KINASE 2; GENE EXPRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; RETROSPECTIVE STUDIES; STATISTICS AS TOPIC; SUPPRESSOR OF CYTOKINE SIGNALING PROTEINS; UP-REGULATION;

EID: 84866893645     PISSN: 00313025     EISSN: 14653931     Source Type: Journal    
DOI: 10.1097/PAT.0b013e328354ffdf     Document Type: Conference Paper

References (25)

1. Rigby RJ, Simmons JG, Greenhalgh CJ, Alexander WS, Lund PK. Suppressor of cytokine signaling 3 (SOCS3) limits damage-induced crypt hyper-proliferation and inflammation-associated tumorigenesis in the colon. Oncogene 2007; 26: 4833-41.
2. Sutherland KD, Vaillant F, Alexander WS, et al. C-myc as a mediator of accelerated apoptosis and involution in mammary glands lacking Socs3. EMBO J 2006; 25: 5805-15.
3. Ogata H, Kobayashi T, Chinen T, et al. Deletion of the SOCS3 gene in liver parenchymal cells promotes hepatitis-induced hepatocarcinogenesis. Gastroenterology 2006; 131: 179-93.
4. Niwa Y, Kanda H, Shikauchi Y, et al. Methylation silencing of SOCS-3 promotes cell growth and migration by enhancing JAK/STAT and FAK signalings inhuman hepatocellular carcinoma. Oncogene 2005; 24: 6406-17.
5. Bellezza I, Neuwirt H, Nemes C, et al. Suppressor of cytokine signaling-3 antagonizes cAMP effects on proliferation and apoptosis and is expressed in human prostate cancer. Am J Pathol 2006; 169: 2199-208.
6. Komyod W, Bohm M, Metze D, Heinrich PC, Behrmann I. Constitutive suppressor of cytokine signaling 3 expression confers a growth advantage to a human melanoma cell line. Mol Cancer Res 2007; 5: 271-81.
7. Shouda T, Hiraoka K, Komiya S, et al. Suppression of IL-6 production and proliferation by blocking STAT3 activation in malignant soft tissue tumor cells. Cancer Lett 2006; 231: 176-84.
8. Sun CK, Ng KT, Sun BS, et al. The significance of proline-rich tyrosine kinase 2 (PYK2) on hepatocellular carcinoma progression and recurrence. Br J Cancer 2007; 97: 50-7.
9. Park SY, Avraham HK, Avraham S. RAFTK/PYK2 activation is mediated by trans-acting autophosphorylation in a Src-dependent manner. J Biol Chem 2004; 279: 33315-22.
10. Zrihan-Licht S, Fu Y, Settleman J, et al. RAFTK/PYK2 tyrosine kinase mediates the association of p190 RhoGAP with RasGAP and is involved in breast cancer cell invasion. Oncogene 2000; 19: 1318-28.
11. Wei L, Yang Y, Zhang X, Yu Q. Altered regulation of Src upon cell detachment protects human lung adenocarcinoma cells from anoikis. Oncogene 2004; 23: 9052-61.
12. Roelle S, Grosse R, Buech T, Chubanov V, Gudermann T. Essential role of PYK2 and Src kinase activation in neuropeptide-induced proliferation of small cell lung cancer cells. Oncogene 2008; 27: 1737-48.
13. Zhang S, Zhang Q, Gu Y, Wang E, Qiu X. Down-regulation of SOCS3 expression by methylation correlates with lymph node metastases of NSCLCs. Zhongguo Fei Ai Za Zhi 2008; 11: 220-5.
14. Zhang S, Qiu X, Gu Y, Wang E. Up-regulation of proline-rich tyrosine kinase 2 in non-small cell lung cancer. Lung Cancer 2008; 62: 295-301.
15. Zhang S, Guo D, Jiang L, Zhang Q, Qiu X, Wang E. SOCS3 inhibiting migration of A549 cells correlates with PYK2 signaling in vitro. BMC Cancer 2008; 8: 150.
16. Travis WD, Colby TV, Corrin B, et al. World Health Organization International Histological Classification of Tumours. Histological Typing of Lung and Pleural Tumours. 3rd ed. Berlin: Springer-Verlag, 1999.
17. Edge SB, Byrd DR, Compton CC, et al., editors. AJCC Cancer Staging Manual. 7th ed. New York: Springer, 2010.
18. Tokita T, Maesawa C, Kimura T, et al. Methylation status of the SOCS3 gene in human malignant melanomas. Int J Oncol 2007; 30: 689-94.
19. Riehle KJ, Campbell JS, McMahan RS, et al. Regulation of liver regeneration and hepatocarcinogenesis by suppressor of cytokine signaling 3. J Exp Med 2008; 205: 91-103.
20. Nagai H, Tokumaru S, Sayama K, et al. Suppressor of cytokine signaling 3 negative regulation of signal transducer and activator of transcription 3 in platelet-derived growth factor-induced fibroblast migration. J Dermatol 2007; 34: 523-30.
21. Weber A, Hengge UR, Bardenheuer W, et al. SOCS-3 is frequently methylated in head and neck squamous cell carcinoma and its precursor lesions and causes growth inhibition. Oncogene 2005; 24: 6699-708.
22. He B, You L, Uematsu K, et al. SOCS-3 is frequently silenced by hypermethylation and suppress cell growth in human lung cancer. Proc Natl Acad Sci USA 2003; 100: 14133-8.
23. Clark MA, Gonzalez N. Src and Pyk2 mediate angiotensin II effects in cultured rat astrocytes. Regul Pept 2007; 143: 47-55.
24. Choi JH, Yang YR, Lee SK, et al. Phospholipase C-gamma1 potentiates integrin-dependent cell spreading and migration through Pyk2/paxillin activation. Cell Signal 2007; 19: 1784-96.
25. Schindler EM, Baumgartner M, Gribben EM, Li L, Efimova T. The role of proline-rich protein tyrosine kinase 2 in differentiation-dependent signaling in human epidermal keratinocytes. J Invest Dermatol 2007; 127: 1094-106.